Preparing the published article.
Company Profile: Microbot Medical Inc.
A profile of Microbot Medical and LIBERTY, covering peripheral endovascular navigation, the specific US FDA clearance, commercial release evidence, and hospital procurement considerations.
Company and application focus
Microbot Medical Inc. develops and distributes LIBERTY, a robotic system for endovascular navigation. Its corporate contact page identifies the company in Hingham, Massachusetts. The regulatory submission names Microbot Medical Ltd. Buyers should establish which group entity supplies the device and supports the installation in their market.
What LIBERTY controls
The LIBERTY product page describes a compact, single-use system with a robotic drive, remote control and mounting arm. It remotely manipulates guidewires and catheters for peripheral vascular navigation. Remote operation here refers to physician control of instruments; it should not be interpreted as an autonomous intervention or a ready-made service for operating between distant hospitals.
US regulatory boundary
The FDA's K243789 letter, dated September 4, 2025, covers the LIBERTY Endovascular Robotic System. The stated scope is remote delivery and manipulation of guidewires and catheters, and manipulation of guide catheters, to facilitate navigation within peripheral vasculature. The manufacturer's current indication explicitly excludes coronary and neurointerventional procedures. This distinction should be carried into any purchasing specification.
A dated commercial milestone
On April 13, 2026, Microbot announced the start of its US full market release. It reported adoption by healthcare systems including Emory Healthcare and Tampa General Hospital. The announcement describes company-reported commercialization, not independent clinical comparison. Hospitals within those networks should not all be counted as active LIBERTY sites merely because the health system adopted the product.
Planning a hospital evaluation
An evaluation should begin with a specific peripheral workflow and the intended operators. Ask the supplier to demonstrate loading, mounting, instrument manipulation and conversion to manual control using the proposed accessories. Record the responsibilities of the physician, scrub team and equipment support staff. Confirm the exact guidewire and catheter compatibility list instead of relying on broad compatibility language.
Include equipment availability, packaging checks, disposal, replenishment and operator training in the acceptance plan. A single-use commercial model still requires a clear account of recurring costs, supporting components and supply continuity.
Evidence and performance questions
Product advertising includes radiation, ergonomics and setup claims. Buyers should examine the underlying study design, measurement conditions and relevance to their own procedures before assigning value to those claims. A clearance document establishes a regulatory determination for the described device and indication; it does not guarantee a particular patient outcome, staff exposure reduction or operating time in every setting.
International and commercial contact
The company provides a general commercial contact address and telephone number through its official contact page. State the purchasing country, institution, intended procedure types and anticipated evaluation schedule. The US release announcement does not establish authorization or stock availability in another country, including the country hosting a conference where the device is presented. Request current local labeling and the responsible service organization.
Questions for the buying team
Which instruments, mounting components and training are included in the proposed package?
How are procedure interruption, replacement supply and support escalation handled?
What local registration and clinical governance documents apply?
Which reference users can discuss the same peripheral workflow?
Explore Medical and Rehabilitation Robots, Write a Robotics Buyer Brief, or Robotics RFQ.